BRCA1 and ovarian carcinoma: It cannot be assumed that the impact of HRT on the recurrence of ovarian cancer in BRCA1/2-pV carriers or pV-carriers in other risk genes for ovarian cancer differs significantly from that of women with sporadic ovarian cancer.